0001392253-19-000001.txt : 20190516 0001392253-19-000001.hdr.sgml : 20190516 20190516110904 ACCESSION NUMBER: 0001392253-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 EFFECTIVENESS DATE: 20190516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENTEGRION INC CENTRAL INDEX KEY: 0001392253 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-250808 FILM NUMBER: 19830987 BUSINESS ADDRESS: STREET 1: 1007 SLATER ROAD STREET 2: SUITE 170 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-536-1500 MAIL ADDRESS: STREET 1: 1007 SLATER ROAD STREET 2: SUITE 170 CITY: DURHAM STATE: NC ZIP: 27703 D/A 1 primary_doc.xml X0708 D/A LIVE 0001392253 ENTEGRION INC 1007 SLATER ROAD SUITE 170 DURHAM NC NORTH CAROLINA 27703 919-536-1500 DELAWARE Hemocellular Therapeutics None Corporation true Richard Martin 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Executive Officer Susan Reyer 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Executive Officer Michael Galiger 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Executive Officer John Mowell 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director Thomas Edwards 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director Christopher Rumana 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director Patrick Nash 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director W Brian Gibler 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director Pierre Noel 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director Robert Capps 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director J True Martin 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director Richard Sacher 1007 Slater Road Suite 170 Durham NC NORTH CAROLINA 27703 Director Biotechnology Decline to Disclose 06b true 0001392253-17-000002 2015-10-23 true true true true false 0 8000000 6662328 1337672 false 73 0 0 0 Proceeds will be used for working capital, which will include normal compensation to executive officers. false ENTEGRION INC Susan Reyer Susan Reyer Chief Financial Officer 2019-05-15